Daniel Vasella Growth Quotations

Our increased level of investment in marketing and sales, with the priority on key growth drivers, resulted in a sales growth of 21 percent in Pharmaceuticals in the U.S.,

Looking ahead, we anticipate a somewhat softer third quarter and, again, a more dynamic fourth quarter resulting in mid-single-digit sales growth... and solid operating growth for the full year,

Market growth in 2006 will slow down somewhat. I expect that we will be able to continue to gain market share.

We are confident of delivering in 2006 another year of dynamic growth with record sales and earnings.

I am pleased with the overall strong performance of our business in the third quarter, particularly the dynamic growth of Pharmaceuticals.